Breaking barriers: Smart vaccine platforms for cancer immunomodulation DOI Creative Commons
Mohammad Mahmoudi Gomari,

Taha Ghantabpour,

Nima Pourgholamamiji

и другие.

Cancer Communications, Год журнала: 2025, Номер unknown

Опубликована: Фев. 3, 2025

Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need explore alternative approaches such as vaccines. Leveraging immune system's natural ability target and kill cells holds great therapeutic potential. However, development of vaccines is hindered by several challenges, including low stability, inadequate response activation, immunosuppressive tumor microenvironment, which limit their efficacy. Recent progress various fields, click chemistry, nanotechnology, exosome engineering, neoantigen design, offer innovative solutions these challenges. These achievements have led emergence smart vaccine platforms (SVPs), integrate protective carriers for messenger ribonucleic acid (mRNA) with functionalization strategies optimize targeted delivery. Click chemistry further enhances SVP performance improving encapsulation mRNA antigens facilitating precise delivery review highlights latest developments technologies therapy, exploring both opportunities challenges advancing transformative approaches.

Язык: Английский

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy DOI Creative Commons
Qiang Lü,

Dongquan Kou,

Shenghan Lou

и другие.

Journal of Hematology & Oncology, Год журнала: 2024, Номер 17(1)

Опубликована: Апрель 2, 2024

Abstract Cancer immunotherapy and vaccine development have significantly improved the fight against cancers. Despite these advancements, challenges remain, particularly in clinical delivery of immunomodulatory compounds. The tumor microenvironment (TME), comprising macrophages, fibroblasts, immune cells, plays a crucial role response modulation. Nanoparticles, engineered to reshape TME, shown promising results enhancing by facilitating targeted These nanoparticles can suppress fibroblast activation, promote M1 macrophage polarization, aid dendritic cell maturation, encourage T infiltration. Biomimetic further enhance increasing internalization agents cells such as cells. Moreover, exosomes, whether naturally secreted body or bioengineered, been explored regulate TME immune-related affect cancer immunotherapy. Stimuli-responsive nanocarriers, activated pH, redox, light conditions, exhibit potential accelerate co-application with checkpoint inhibitors is an emerging strategy boost anti-tumor immunity. With their ability induce long-term immunity, nanoarchitectures are structures development. This review underscores critical overcoming current driving advancement modification.

Язык: Английский

Процитировано

131

Aggregation‐Induced Emission‐Based Macrophage‐Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in Monkeypox DOI
Bin Li, Wei Wang, Lu Zhao

и другие.

Advanced Materials, Год журнала: 2023, Номер 36(9)

Опубликована: Ноя. 6, 2023

The recent prevalence of monkeypox has led to the declaration a Public Health Emergency International Concern. Monkeypox lesions are typically ulcers or pustules (containing high titers replication-competent virus) in skin and mucous membranes, which allow virus transmit predominantly through intimate contact. Currently, effective clinical treatments for lacking, strategies blocking transmission fraught with drawbacks. Herein, this work constructs biomimetic nanotemplate (termed TBD@M NPs) macrophage membranes as coat polymeric nanoparticles loading versatile aggregation-induced emission featured photothermal molecule TPE-BT-DPTQ core. In surrogate mouse model (vaccinia-virus-infected tail scarification model), intravenously injected NPs show precise tracking near-infrared region II fluorescence imaging lesions. Upon 808 nm laser irradiation, is eliminated by effect infected wound heals rapidly. More importantly, inoculation treated lesion tissue suspensions does not trigger infection inflammatory activation healthy mice, indicating successful blockage transmission. This study demonstrates first time theranostics using nanomedicine, may bring new insight into development viable strategy management trials.

Язык: Английский

Процитировано

93

Biomimetic and bioinspired nano‐platforms for cancer vaccine development DOI Creative Commons

Chenchao Feng,

Peng Tan, Guangjun Nie

и другие.

Exploration, Год журнала: 2023, Номер 3(3)

Опубликована: Апрель 25, 2023

The advent of immunotherapy has revolutionized the treating modalities cancer. Cancer vaccine, aiming to harness host immune system induce a tumor-specific killing effect, holds great promises for its broad patient coverage, high safety, and combination potentials. Despite promising, clinical translation cancer vaccines faces obstacles including lack potency, limited options tumor antigens adjuvants, immunosuppressive microenvironment. Biomimetic bioinspired nanotechnology provides new impetus designing concepts vaccines. Through mimicking stealth coating, pathogen recognition pattern, tissue tropism pathogen, other irreplaceable properties from nature, biomimetic could gain functions such as longstanding, targeting, self-adjuvanting, on-demand cargo release. specific behavior endogenous molecules each type living entity (cell or microorganism) offer unique features address needs immunotherapy. In this review, strategies inspired by eukaryotic cells, bacteria, viruses will be overviewed advancing vaccine development. Our insights into future development shared at end expediting translation.

Язык: Английский

Процитировано

78

Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review DOI Creative Commons
Zhen Chen, Min Xiong, Jiaqi Tian

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Янв. 3, 2024

Abstract Exosomes are nanoscale extracellular vesicles secreted by cells and enclosed a lipid bilayer membrane containing various biologically active cargoes such as proteins, lipids, nucleic acids. Engineered exosomes generated through genetic modification of parent show promise drug delivery vehicles, they have been demonstrated to great therapeutic potential for treating cancer, cardiovascular, neurological, immune diseases, but systematic knowledge is lacking regarding optimization loading assessment efficacy. This review summarizes current approaches engineering evaluating their effects, techniques assessing exosome release kinetics, cell targeting, biodistribution, pharmacokinetics, outcomes critically examined. Additionally, this synthesizes the latest applications in clinical translation. The compiled provides framework rational design rigorous therapeutics. Continued advancement robust characterization methods reporting standards will accelerate development technologies pave way studies. Graphical

Язык: Английский

Процитировано

36

Multi-pathway oxidative stress amplification via controllably targeted nanomaterials for photoimmunotherapy of tumors DOI Creative Commons
Hang Li,

Yunheng Liu,

Xiaokang Zhang

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Янв. 22, 2025

Photoimmunotherapy, which combines phototherapy with immunotherapy, exhibits significantly improved therapeutic effects compared mono-treatment regimens. However, its use is associated drawbacks, such as insufficient reactive oxygen species (ROS) production and uneven photosensitizer distribution. To address these issues, we developed a controllable, targeted nanosystem that enhances oxidative stress through multiple pathways, achieving synergistic photothermal, photodynamic, immunotherapy for tumor treatment. These nanoparticles (D/I@HST NPs) accurately target overexpressed transferrin receptors (TfRs) on the surface of cells surface-modified (Tf). After endocytosis, D/I@HST NPs generate ROS under 808-nm laser irradiation, breaking ROS-responsive crosslinking agent increasing drug release utilization. Tf also carries Fe3+, reduced to Fe2+ by iron reductase in acidic microenvironment (TME). Consequently, endoperoxide bridge structure dihydroartemisinin cleaved, causing additional generation. Furthermore, released IR-780 exerts both photodynamic photothermal effects, enhancing cell death. This multi-pathway amplification effect can trigger immunogenic death tumors, promoting relevant antigens damage-associated molecular patterns, thereby dendritic maturation sensitivity immunotherapy. Mature transmit signals T cells, infiltration activation, facilitating growth inhibition suppression lung metastasis. myeloid-derived suppressor decreases after In summary, this stress-amplified effectively inhibits reverses immunosuppressive microenvironment, provides new insights into combined phototherapy.

Язык: Английский

Процитировано

2

Oral Nanomedicine: Challenges and Opportunities DOI

Bo Deng,

Shaomin Liu, Ying Wang

и другие.

Advanced Materials, Год журнала: 2023, Номер 36(6)

Опубликована: Сен. 19, 2023

Abstract Compared to injection administration, oral administration is free of discomfort, wound infection, and complications has a higher compliance rate for patients with diverse diseases. However, reduces the bioavailability medicines, especially biologics (e.g., peptides, proteins, antibodies), due harsh gastrointestinal biological barriers. In this context, development prosperity nanotechnology have helped improve bioactivity availability medicines. On basis, first, barriers are discussed, then nanomedicine based on organic inorganic nanomaterials their biomedical applications in diseases reviewed. Finally, challenges potential opportunities future nanomedicine, which may provide vital reference eventual clinical transformation standardized production put forward.

Язык: Английский

Процитировано

30

Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery DOI
Qimanguli Saiding, Zhongyang Zhang, Shuying Chen

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2023, Номер 203, С. 115116 - 115116

Опубликована: Окт. 21, 2023

Язык: Английский

Процитировано

28

EISA in Tandem with ICD to Form In Situ Nanofiber Vaccine for Enhanced Tumor Radioimmunotherapy DOI

Hongjing Luo,

Hongmei Cao,

Haixue Jia

и другие.

Advanced Healthcare Materials, Год журнала: 2023, Номер 12(27)

Опубликована: Июнь 10, 2023

Radiotherapy (RT) can produce a vaccine effect and remodel tumor microenvironment (TME) by inducing immunogenic cell death (ICD) inflammation in tumors. However, RT alone is insufficient to elicit systemic antitumor immune response owing limited antigen presentation, immunosuppressive microenvironment, chronic within the tumor. Here, novel strategy reported for generation of situ peptide-based nanovaccines via enzyme-induced self-assembly (EISA) tandem with ICD. As ICD progresses, peptide Fbp-GD FD pY (Fbp-pY), dephosphorylated alkaline phosphatase (ALP) forms fibrous nanostructure around cells, resulting capture encapsulation autologous antigens produced radiation. Utilizing adjuvant controlled-release advantages self-assembling peptides, this nanofiber effectively increases accumulation lymph nodes cross-presentation antigen-presenting cells (APCs). In addition, inhibition cyclooxygenase 2 (COX-2) expression nanofibers promotes repolarization M2-macrophages into M1 reduces number regulatory T (Tregs) myeloid-derived suppressor (MDSCs) required TME remodeling. result, combination significantly enhances therapeutic on 4T1 tumors compared alone, suggesting promising treatment radioimmunotherapy.

Язык: Английский

Процитировано

22

Cell Membrane‐Coated Nanoparticles: A New Frontier in Immunomodulation DOI Creative Commons
Nimeet Desai, Vishakha Tambe, Prasad Pofali

и другие.

Advanced NanoBiomed Research, Год журнала: 2024, Номер 4(8)

Опубликована: Май 31, 2024

Immune dysregulation is a pivotal factor in the onset and progression of various diseases. In cancer, immune system's inability to discern eliminate abnormal cells leads uncontrolled tumor growth. When faced with resilient pathogens or harmful toxins, system encounters challenges clearance neutralization. Achieving delicate balance pro‐inflammatory anti‐inflammatory signals essential managing range disorders Like other biomedical research domains, nanotechnology has provided innovative approaches for rebalancing host immunity. Among plethora nanotechnology‐based interventions, concept cell membrane‐coated nanoparticles holds significant potential immunomodulatory applications owing their biomimetic properties that allow precise interaction compromised system. This review thoroughly examines novel nanosystems modulation. The exploration covers crucial elements, including origins characteristics membranes, methods employed procurement coating, physicochemical/biological characterization techniques, enhancement therapeutic efficacy via functionalization. Subsequently, case studies‐based analysis utilizing these bioinspired tackling different conditions caused by disturbance been comprehensively discussed.

Язык: Английский

Процитировано

10

A Mn2+‐Assisted Nanofiber‐Hydrogel Adjuvant for Simultaneous Enhancement of Humoral and Cellular Immune Responses DOI

Haixue Jia,

Lin Jia,

Dianyu Wang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(30)

Опубликована: Апрель 9, 2024

Abstract Limited ability to elicit cellular immune responses has restricted the effectiveness of conventional adjuvants in context cancers. Recent advancements innate activation mechanism investigations have paved way for implementation a “bottom‐up” approach development novel adjuvants. Herein, simple hydrogel adjuvant with uniformly organized nanoscale microstructure, termed MnP gel is devised, by employing self‐assembling peptides incorporated manganese ions (Mn 2+ ). exhibits Mn sustained‐release properties vivo and effectively promotes germinal center formation, thereby facilitating generation antibodies at levels comparable aluminum‐based Moreover, transcends scope humoral immunity, demonstrating robustly trigger positioning it as promising candidate cancer prevention treatments. In conclusion, work introduced well‐defined proof‐of‐concept, simplifying vaccine design opening up new avenues “on‐demand” immunomodulation strategies.

Язык: Английский

Процитировано

8